We are live on ! Find out more
WHWK

Whitehawk Therapeutics
WHWK

41 hedge funds and large institutions have $54.3M invested in Whitehawk Therapeutics in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

5% more funds holding

Funds holding: 39 → 41 (+2)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% less capital invested

Capital invested by funds: $54.6M → $54.3M (-$268K)

1.3% less ownership

Funds ownership: 62.48% → 61.18% (-1.3%)

50% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 10

Holders
41
Holders Change
+2
Holders Change %
+5.13%
% of All Funds
0.54%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
5
Increased
5
Reduced
10
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SC
Stempoint Capital
New York
+$780K
2
Citadel Advisors
Citadel Advisors
Florida
+$205K
3
PLC
Peapod Lane Capital
New York
+$113K
4
SCM
Stonepine Capital Management
Oregon
+$64.8K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$50.8K

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$2.04M
2
BCM
Bridgeway Capital Management
Texas
-$184K
3
Jane Street
Jane Street
New York
-$147K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$49K
5
Northern Trust
Northern Trust
Illinois
-$37K
Name Holding Trade Value Shares
Change 		Change in
Stake
XT
26
XTX Topco
Cayman Islands
$37.6K +$36.4K +19,780 New
UBS Group
27
UBS Group
Switzerland
$10.8K -$5.48K -2,980 -34%
US Bancorp
28
US Bancorp
Minnesota
$6.33K – – –
Osaic Holdings
29
Osaic Holdings
Arizona
$5.89K – – –
Morgan Stanley
30
Morgan Stanley
New York
$3.51K -$283 -154 -8%
BCWM
31
Bartlett & Co Wealth Management
Ohio
$2.53K – – –
TRCT
32
Tower Research Capital (TRC)
New York
$1.51K -$6.07K -3,301 -81%
JP Morgan Chase
33
JP Morgan Chase
New York
$800 – – –
Russell Investments Group
34
Russell Investments Group
United Kingdom
$733 – – –
TWC
35
TD Waterhouse Canada
Ontario, Canada
$443 – – –
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
$304 – – –
Bank of America
37
Bank of America
North Carolina
$87 -$671 -365 -89%
SS
38
SBI Securities
Japan
$36 – – –
PA
39
Parallel Advisors
California
$15 – – –
EC
40
EcoR1 Capital
California
– -$2.04M -1,091,417 Closed
TSS
41
Two Sigma Securities
New York
– -$20.8K -11,103 Closed
Federated Hermes
42
Federated Hermes
Pennsylvania
– -$669 -358 Closed
Simplex Trading
43
Simplex Trading
Illinois
– +$64 +35 New
1
2

WHWK Hedge Fund Activity: Q3 2025 in Review

41 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Whitehawk Therapeutics (WHWK) for Q3 2025, worth a combined $54.3M — down 0.49% from $54.6M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new WHWK positions and 3 closed out — a net gain of 2 holders — while 5 added to existing stakes and 10 trimmed.

The largest buyer was Stempoint Capital, opening a new position worth an estimated $780K. The largest seller was EcoR1 Capital, exiting entirely with an estimated $2.04M sold.

  • 41 institutional investors held Whitehawk Therapeutics (WHWK) as of Q3 2025, up from 39 in Q2 2025.
  • Funds reported $54.3M of Whitehawk Therapeutics stock for Q3 2025, down 0.49% quarter-over-quarter.
  • 5 funds opened new Whitehawk Therapeutics positions in Q3 2025 and 3 closed out, a net change of +2 holders.
  • The largest Whitehawk Therapeutics buyer in Q3 2025 was Stempoint Capital, an estimated $780K added.
  • The largest Whitehawk Therapeutics seller in Q3 2025 was EcoR1 Capital, an estimated $2.04M sold.

Based on aggregated 13F filings for Q3 2025.